OXYTOCIN

OXYTOCIN was reported 3046 times

OXYTOCIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INTERMITTENT POSITIVE PRESSURE BREATHING 10 0.7143
1 STROKE VOLUME INCREASED 5 0.2632
2 FOETAL HEART RATE INDETERMINATE 2 0.2500
3 UTERINE INVERSION 5 0.2273
4 AMNIOTIC FLUID EMBOLUS 2 0.2222
5 UTERINE ATONY 53 0.2023
6 VASCULAR RESISTANCE SYSTEMIC INCREASED 10 0.1923
7 FOETAL ANAEMIA 24 0.1832
8 CRANIORACHISCHISIS 5 0.1667
9 ANAPHYLACTOID SYNDROME OF PREGNANCY 14 0.1458
10 INJURY TO BRACHIAL PLEXUS DUE TO BIRTH TRAUMA 2 0.1429
11 MATERNAL EXPOSURE DURING DELIVERY 137 0.1382
12 ARTIFICIAL RUPTURE OF MEMBRANES 3 0.1304
13 POSTPARTUM HAEMORRHAGE 155 0.1150
14 PERICORONITIS 10 0.1099
15 PERINEAL LACERATION 2 0.1000
16 POSTPARTUM VENOUS THROMBOSIS 2 0.0952
17 VENTILATION PERFUSION MISMATCH 24 0.0854
18 EVACUATION OF RETAINED PRODUCTS OF CONCEPTION 2 0.0833
19 UTERINE HYPOTONUS 10 0.0794
20 RETAINED PLACENTA OR MEMBRANES 24 0.0792
21 AMNIOTIC FLUID VOLUME INCREASED 12 0.0759
22 UTERINE TACHYSYSTOLE 11 0.0759
23 CEREBRAL HAEMORRHAGE NEONATAL 16 0.0755
24 BASELINE FOETAL HEART RATE VARIABILITY DISORDER 4 0.0727
25 CONJOINED TWINS 7 0.0707
26 PLACENTA ACCRETA 14 0.0645
27 INTRAPARTUM HAEMORRHAGE 5 0.0625
28 FAILED INDUCTION OF LABOUR 12 0.0619
29 VASCULAR RESISTANCE SYSTEMIC DECREASED 8 0.0597
30 MECONIUM STAIN 9 0.0584
31 OBSTETRIC PROCEDURE COMPLICATION 2 0.0541
32 NONREASSURING FOETAL HEART RATE PATTERN 12 0.0541
33 FOETAL ACIDOSIS 3 0.0536
34 FOETAL EXPOSURE DURING DELIVERY 36 0.0531
35 POSTPARTUM SEPSIS 3 0.0526
36 RIGHT ATRIAL PRESSURE INCREASED 4 0.0494
37 UTERINE HYPERSTIMULATION 5 0.0490
38 PERIPARTUM HAEMORRHAGE 2 0.0488
39 UTERINE HYPERTONUS 13 0.0480
40 VACUUM EXTRACTOR DELIVERY 4 0.0476
41 HEPATOSPLENOMEGALY NEONATAL 2 0.0476
42 POST PROCEDURAL HYPOTENSION 4 0.0471
43 BRADYCARDIA FOETAL 39 0.0469
44 CARDIAC OUTPUT INCREASED 8 0.0468
45 PERINEAL INJURY 7 0.0461
46 PERIVENTRICULAR LEUKOMALACIA 13 0.0459
47 FOETAL HEART RATE DECELERATION ABNORMALITY 32 0.0453
48 FOETAL HEART RATE DECELERATION 10 0.0431
49 OBSTRUCTED LABOUR 7 0.0412
50 PERIPARTUM CARDIOMYOPATHY 7 0.0407
51 SHOULDER DYSTOCIA 6 0.0395
52 FORCEPS DELIVERY 5 0.0385
53 TACHYCARDIA FOETAL 19 0.0381
54 ARRESTED LABOUR 9 0.0380
55 EPIDURAL ANAESTHESIA 2 0.0357
56 POSITIVE AIRWAY PRESSURE THERAPY 10 0.0342
57 CENTRAL VENOUS PRESSURE INCREASED 4 0.0328
58 AMNIOTIC CAVITY INFECTION 23 0.0318
59 MEAN ARTERIAL PRESSURE DECREASED 8 0.0316
60 UTERINE HAEMATOMA 4 0.0315
61 CEREBROVASCULAR SPASM 4 0.0303
62 PARVOVIRUS B19 TEST POSITIVE 2 0.0282
63 HARLEQUIN SYNDROME 2 0.0274
64 CERVIX DYSTOCIA 3 0.0265
65 UTERINE RUPTURE 37 0.0261
66 RENAL CORTICAL NECROSIS 6 0.0258
67 BRIEF PSYCHOTIC DISORDER, WITH POSTPARTUM ONSET 2 0.0256
68 FOETAL HEART RATE DECREASED 16 0.0256
69 UMBILICAL CORD PROLAPSE 3 0.0244
70 HORNER'S SYNDROME 2 0.0241
71 HYPERBILIRUBINAEMIA NEONATAL 14 0.0241
72 FOETAL MONITORING ABNORMAL 4 0.0240
73 WHITE MATTER LESION 30 0.0237
74 URINARY BLADDER RUPTURE 6 0.0236
75 ABNORMAL LABOUR 3 0.0233
76 ANAEMIA OF PREGNANCY 4 0.0231
77 SUBCHORIONIC HAEMATOMA 4 0.0227
78 ENDOMETRITIS 15 0.0226
79 NEUROMUSCULAR BLOCKADE 5 0.0223
80 UTERINE CONTRACTIONS ABNORMAL 6 0.0221
81 APGAR SCORE LOW 28 0.0217
82 DELIVERY 14 0.0212
83 NEONATAL ASPHYXIA 15 0.0212
84 HAEMANGIOMA CONGENITAL 10 0.0211
85 NEONATAL DYSPNOEA 2 0.0211
86 CONVULSION NEONATAL 11 0.0208
87 POSTICTAL PARALYSIS 5 0.0207
88 PULMONARY ARTERY STENOSIS 8 0.0204
89 CEPHALO-PELVIC DISPROPORTION 4 0.0200
90 FOETAL MOVEMENTS DECREASED 2 0.0196
91 URINOMA 3 0.0190
92 INDUCED LABOUR 11 0.0185
93 OXYGEN SATURATION IMMEASURABLE 2 0.0182
94 CEPHALHAEMATOMA 2 0.0180
95 POOR SUCKING REFLEX 7 0.0176
96 RENAL VASCULAR THROMBOSIS 3 0.0175
97 ECLAMPSIA 6 0.0163
98 NEONATAL BEHAVIOURAL SYNDROME 5 0.0163
99 ERGOT POISONING 2 0.0160
100 CHORIOAMNIONITIS 3 0.0158
101 FOETAL HEART RATE DISORDER 3 0.0155
102 FOETAL HEART RATE ABNORMAL 14 0.0151
103 NEONATAL RESPIRATORY DEPRESSION 5 0.0151
104 HELLP SYNDROME 9 0.0147
105 RENAL APLASIA 10 0.0142
106 MECONIUM IN AMNIOTIC FLUID 5 0.0142
107 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 15 0.0141
108 WRONG PRODUCT STORED 4 0.0141
109 HYPOTHERMIA NEONATAL 2 0.0140
110 NEONATAL RESPIRATORY DISTRESS 13 0.0138
111 POLYHYDRAMNIOS 14 0.0137
112 POSTMATURE BABY 2 0.0137
113 PRODUCT COMPOUNDING QUALITY ISSUE 5 0.0137
114 ACID BASE BALANCE ABNORMAL 3 0.0134
115 PERITONEAL HAEMATOMA 2 0.0133
116 PROLONGED LABOUR 8 0.0131
117 LOW BIRTH WEIGHT BABY 104 0.0131
118 NEONATAL TACHYCARDIA 2 0.0129
119 JAUNDICE NEONATAL 24 0.0127
120 PREGNANCY INDUCED HYPERTENSION 2 0.0124
121 HYPOGLYCAEMIA NEONATAL 20 0.0124
122 FEEDING DISORDER OF INFANCY OR EARLY CHILDHOOD 2 0.0122
123 NORMAL NEWBORN 65 0.0119
124 CONGENITAL CYSTIC KIDNEY DISEASE 10 0.0118
125 ACUTE RIGHT VENTRICULAR FAILURE 2 0.0118
126 RESPIRATORY DISORDER NEONATAL 19 0.0117
127 SMALL FOR DATES BABY 58 0.0117
128 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 25 0.0114
129 PITUITARY APOPLEXY 2 0.0114
130 PREMATURE RUPTURE OF MEMBRANES 27 0.0112
131 MACROSOMIA 2 0.0110
132 IN VITRO FERTILISATION 2 0.0110
133 INFANTILE APNOEA 9 0.0110
134 FLOPPY INFANT 2 0.0109
135 FOETAL MACROSOMIA 3 0.0108
136 HYPERMAGNESAEMIA 7 0.0107
137 COLOBOMA 2 0.0107
138 PREMATURE DELIVERY 163 0.0102
139 TRANSIENT TACHYPNOEA OF THE NEWBORN 4 0.0101
140 GESTATIONAL HYPERTENSION 13 0.0101
141 PLACENTAL INSUFFICIENCY 8 0.0100
142 FOETAL DISTRESS SYNDROME 21 0.0099
143 HYPOXIC ENCEPHALOPATHY 4 0.0098
144 THROMBOCYTOPENIA NEONATAL 4 0.0095
145 CEREBRAL VASOCONSTRICTION 7 0.0095
146 PRE-ECLAMPSIA 44 0.0092
147 MATERNAL CONDITION AFFECTING FOETUS 2 0.0090
148 CAESAREAN SECTION 105 0.0090
149 MYOTONIA 2 0.0090
150 PLACENTAL INFARCTION 2 0.0090
151 OPERATIVE HAEMORRHAGE 4 0.0089
152 SELECTIVE EATING DISORDER 8 0.0088
153 LAPAROTOMY 4 0.0088
154 PULMONARY ARTERY DILATATION 3 0.0087
155 FOETAL DEATH 45 0.0087
156 LABOUR COMPLICATION 2 0.0085
157 UMBILICAL CORD AROUND NECK 5 0.0085
158 NEURAL TUBE DEFECT 6 0.0083
159 PROCEDURAL HYPOTENSION 7 0.0082
160 NEONATAL HYPOTENSION 3 0.0082
161 SUDDEN INFANT DEATH SYNDROME 4 0.0081
162 GESTATIONAL DIABETES 38 0.0080
163 WATER INTOXICATION 4 0.0079
164 HYPONATRAEMIC SEIZURE 2 0.0079
165 POSTPARTUM DEPRESSION 2 0.0078
166 CYANOSIS NEONATAL 5 0.0078
167 PRODUCT BARCODE ISSUE 3 0.0078
168 DENTURE WEARER 2 0.0077
169 PRETERM PREMATURE RUPTURE OF MEMBRANES 9 0.0075
170 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 8 0.0074
171 AMNIOTIC FLUID VOLUME DECREASED 4 0.0073
172 CATHETER SITE THROMBOSIS 2 0.0073
173 LIVE BIRTH 61 0.0073
174 PREMATURE SEPARATION OF PLACENTA 11 0.0071
175 DAIRY INTOLERANCE 2 0.0071
176 UTERINE HAEMORRHAGE 30 0.0070
177 PREMATURE BABY 209 0.0069
178 COMPLICATION OF DELIVERY 2 0.0069
179 HYPOSPADIAS 14 0.0067
180 FEEDING DISORDER NEONATAL 7 0.0067
181 CONGENITAL CHOROID PLEXUS CYST 2 0.0066
182 NEONATAL RESPIRATORY DISTRESS SYNDROME 23 0.0065
183 PELVIC INFECTION 3 0.0065
184 DELAYED RECOVERY FROM ANAESTHESIA 6 0.0063
185 BLADDER INJURY 2 0.0063
186 ELECTROMECHANICAL DISSOCIATION 5 0.0063
187 ELECTROCARDIOGRAM QRS COMPLEX ABNORMAL 2 0.0062
188 ANAEMIA NEONATAL 3 0.0062
189 LACTATION DISORDER 3 0.0062
190 PACKAGING DESIGN ISSUE 2 0.0061
191 NEONATAL HYPOXIA 5 0.0060
192 PATENT DUCTUS ARTERIOSUS 24 0.0060
193 EXPOSURE DURING PREGNANCY 366 0.0059
194 EPIDURAL LIPOMATOSIS 2 0.0058
195 NEONATAL INFECTION 2 0.0058
196 GASTROINTESTINAL VIRAL INFECTION 6 0.0058
197 UMBILICAL CORD ABNORMALITY 3 0.0057
198 KIDNEY MALFORMATION 2 0.0057
199 FOETAL EXPOSURE DURING PREGNANCY 456 0.0056
200 BRADYCARDIA NEONATAL 7 0.0056
201 BREECH PRESENTATION 7 0.0056
202 STILLBIRTH 26 0.0054
203 PATERNAL DRUGS AFFECTING FOETUS 2 0.0053
204 HYDROURETER 2 0.0053
205 FOETAL GROWTH RESTRICTION 32 0.0053
206 FACIAL ASYMMETRY 5 0.0052
207 EUSTACHIAN TUBE DYSFUNCTION 3 0.0052
208 HYPEREMESIS GRAVIDARUM 2 0.0052
209 CEREBRAL VENTRICLE DILATATION 6 0.0052
210 BREAST FEEDING 4 0.0051
211 BLIGHTED OVUM 2 0.0051
212 PLACENTA PRAEVIA 4 0.0051
213 NEONATAL DISORDER 8 0.0050
214 GRUNTING 3 0.0050
215 MATERNAL EXPOSURE DURING PREGNANCY 441 0.0049
216 NEONATAL TACHYPNOEA 2 0.0048
217 EXPOSURE DURING BREAST FEEDING 16 0.0048
218 ACUTE PULMONARY OEDEMA 27 0.0048
219 OTITIS MEDIA CHRONIC 2 0.0048
220 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 6 0.0048
221 DUCTUS ARTERIOSUS STENOSIS FOETAL 2 0.0047
222 MATERNAL EXPOSURE DURING BREAST FEEDING 19 0.0047
223 INTERCEPTED DRUG ADMINISTRATION ERROR 2 0.0046
224 MITRAL VALVE STENOSIS 3 0.0045
225 MATERNAL DRUGS AFFECTING FOETUS 33 0.0043
226 FOETAL HYPOKINESIA 3 0.0043
227 PLACENTAL DISORDER 4 0.0042
228 RESUSCITATION 7 0.0042
229 CEREBRAL PALSY 4 0.0042
230 DRUG EXPOSURE DURING PREGNANCY 143 0.0042
231 OLIGOHYDRAMNIOS 14 0.0042
232 VENTRICULAR SEPTAL DEFECT 24 0.0042
233 CERVIX DISORDER 3 0.0042
234 PCO2 DECREASED 4 0.0041
235 DYSLALIA 3 0.0041
236 ANAESTHETIC COMPLICATION 11 0.0041
237 TEMPERATURE REGULATION DISORDER 9 0.0040
238 NEONATAL RESPIRATORY FAILURE 2 0.0040
239 CERVICAL INCOMPETENCE 2 0.0039
240 FEMALE STERILISATION 2 0.0039
241 FOETAL GROWTH RETARDATION 3 0.0038
242 PULMONARY VALVE STENOSIS 3 0.0038
243 ANAL ATRESIA 2 0.0037
244 PREMATURE LABOUR 21 0.0037
245 DEATH NEONATAL 5 0.0036
246 VITH NERVE PARALYSIS 4 0.0035
247 PO2 DECREASED 4 0.0035
248 UTERINE DISORDER 8 0.0034
249 CLEFT LIP 3 0.0034
250 NERVE BLOCK 2 0.0034
251 LIMB REDUCTION DEFECT 2 0.0034
252 PULMONARY VALVE INCOMPETENCE 5 0.0034
253 HEART DISEASE CONGENITAL 12 0.0034
254 MENINGOMYELOCELE 2 0.0033
255 PERSISTENT FOETAL CIRCULATION 2 0.0033
256 HYDROPS FOETALIS 2 0.0033
257 BLOOD PRESSURE IMMEASURABLE 5 0.0033
258 PRODUCT APPEARANCE CONFUSION 3 0.0032
259 OESOPHAGEAL ATRESIA 2 0.0032
260 MATERNAL EXPOSURE TIMING UNSPECIFIED 12 0.0032
261 TRISOMY 21 4 0.0032
262 INTRA-UTERINE DEATH 5 0.0031
263 DISTRIBUTIVE SHOCK 7 0.0031
264 PULMONARY ARTERIAL PRESSURE INCREASED 5 0.0031
265 COMPLICATIONS OF MATERNAL EXPOSURE TO THERAPEUTIC DRUGS 2 0.0029
266 BLOOD PH DECREASED 5 0.0029
267 UTERINE PAIN 3 0.0029
268 UTERINE CONTRACTIONS DURING PREGNANCY 3 0.0029
269 PERITONEAL HAEMORRHAGE 4 0.0029
270 TONGUE OEDEMA 11 0.0029
271 FUSARIUM INFECTION 2 0.0029
272 PERINEAL PAIN 2 0.0028
273 HAEMORRHAGE IN PREGNANCY 4 0.0028
274 FOETAL EXPOSURE TIMING UNSPECIFIED 2 0.0028
275 CHYLOTHORAX 2 0.0028
276 INFECTION SUSCEPTIBILITY INCREASED 6 0.0027
277 PRODUCT SELECTION ERROR 3 0.0027
278 CLEFT LIP AND PALATE 3 0.0027
279 SUSPECTED OFF LABEL USE 12 0.0027
280 COMPLICATION OF PREGNANCY 2 0.0026
281 LIMB ASYMMETRY 2 0.0026
282 THERAPEUTIC PRODUCT EFFECT INCREASED 3 0.0026
283 PHARYNGEAL PARAESTHESIA 4 0.0025
284 EMBOLIA CUTIS MEDICAMENTOSA 2 0.0025
285 EXPOSURE VIA BREAST MILK 10 0.0025
286 HAEMODYNAMIC INSTABILITY 19 0.0025
287 MATERNAL EXPOSURE BEFORE PREGNANCY 17 0.0025
288 INCISION SITE HAEMORRHAGE 2 0.0025
289 HYPOTHERMIA 24 0.0024
290 TROPONIN T INCREASED 3 0.0024
291 LEFT ATRIAL DILATATION 3 0.0024
292 DISSEMINATED INTRAVASCULAR COAGULATION 33 0.0023
293 MICROCEPHALY 3 0.0023
294 CRANIOSYNOSTOSIS 2 0.0023
295 INTERCEPTED PRODUCT SELECTION ERROR 3 0.0023
296 LARGE FOR DATES BABY 2 0.0023
297 VENTRICULAR HYPOKINESIA 7 0.0022
298 RHONCHI 3 0.0022
299 EXTENSOR PLANTAR RESPONSE 2 0.0022
300 MECHANICAL VENTILATION 4 0.0021
301 ATRIAL SEPTAL DEFECT 17 0.0020
302 UNDERWEIGHT 4 0.0020
303 DRUG EXPOSURE BEFORE PREGNANCY 2 0.0020
304 AUTISM 2 0.0020
305 OLIGURIA 12 0.0019
306 BONE MARROW OEDEMA 2 0.0019
307 ELECTROCARDIOGRAM T WAVE ABNORMAL 3 0.0019
308 HYPOTONIA NEONATAL 3 0.0019
309 DILATATION VENTRICULAR 4 0.0019
310 MEDICAL DEVICE PAIN 4 0.0019
311 INTRACRANIAL VENOUS SINUS THROMBOSIS 2 0.0019
312 DRUG EXPOSURE VIA BREAST MILK 2 0.0018
313 PROCEDURAL HAEMORRHAGE 7 0.0018
314 ENDOTRACHEAL INTUBATION 5 0.0018
315 EROSIVE OESOPHAGITIS 3 0.0018
316 BLOOD FIBRINOGEN DECREASED 2 0.0018
317 SPINAL CORD INJURY 3 0.0017
318 HYPOVOLAEMIA 10 0.0017
319 PHYSICAL PRODUCT LABEL ISSUE 2 0.0017
320 HYPERCAPNIA 5 0.0017
321 PRODUCT PACKAGING CONFUSION 4 0.0016
322 INCORRECT DRUG ADMINISTRATION RATE 7 0.0016
323 UTERINE SPASM 3 0.0016
324 WRONG PRODUCT ADMINISTERED 11 0.0016
325 HYSTERECTOMY 14 0.0016
326 DEVICE INFUSION ISSUE 4 0.0016
327 HYPOTONIA 16 0.0016
328 VASODILATATION 4 0.0016
329 ORTHOPNOEA 5 0.0016
330 INCREASED BRONCHIAL SECRETION 4 0.0016
331 CLEFT PALATE 3 0.0016
332 IATROGENIC INJURY 2 0.0016
333 PERIORBITAL OEDEMA 8 0.0015
334 ADRENOCORTICAL INSUFFICIENCY ACUTE 3 0.0015
335 HYPOXIA 54 0.0015
336 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 4 0.0015
337 DEVICE MISUSE 2 0.0015
338 INTESTINAL DILATATION 2 0.0015
339 LARYNGOSPASM 4 0.0015
340 CARDIOVERSION 2 0.0014
341 MENINGITIS BACTERIAL 2 0.0014
342 FACIAL PALSY 3 0.0014
343 RALES 8 0.0014
344 SENSORY LOSS 11 0.0014
345 ELECTROCARDIOGRAM T WAVE INVERSION 3 0.0014
346 HYPERTHERMIA MALIGNANT 2 0.0013
347 CHOLECYSTITIS CHRONIC 9 0.0013
348 CREPITATIONS 4 0.0013
349 PARTIAL SEIZURES 7 0.0013
350 UTERINE PERFORATION 11 0.0013
351 BACTERIAL VAGINOSIS 2 0.0013
352 VIRAL UPPER RESPIRATORY TRACT INFECTION 6 0.0013
353 INTRA-ABDOMINAL HAEMORRHAGE 3 0.0013
354 LIMB DEFORMITY 2 0.0013
355 IMMUNOSUPPRESSION 11 0.0012
356 DIABETES INSIPIDUS 3 0.0012
357 SHOCK HAEMORRHAGIC 10 0.0012
358 INTERCEPTED PRODUCT DISPENSING ERROR 2 0.0012
359 PRODUCT LABEL CONFUSION 7 0.0012
360 ANAPHYLACTIC REACTION 66 0.0012
361 GAZE PALSY 2 0.0012
362 APNOEA 9 0.0012
363 CARDIAC MURMUR 10 0.0012
364 KIDNEY FIBROSIS 2 0.0012
365 COMPARTMENT SYNDROME 3 0.0011
366 CYANOSIS 18 0.0011
367 THROMBOPHLEBITIS 4 0.0011
368 AREFLEXIA 3 0.0011
369 CYTOMEGALOVIRUS TEST POSITIVE 2 0.0011
370 APPARENT DEATH 4 0.0011
371 PREGNANCY 22 0.0011
372 PATHOGEN RESISTANCE 10 0.0011
373 CLONUS 3 0.0011
374 DRUG DOSE TITRATION NOT PERFORMED 2 0.0011
375 LOBAR PNEUMONIA 2 0.0011
376 STATUS EPILEPTICUS 12 0.0011
377 PULMONARY OEDEMA 47 0.0010
378 GALLBLADDER INJURY 2 0.0010
379 ABDOMINAL WALL HAEMATOMA 2 0.0010
380 RESPIRATORY RATE INCREASED 9 0.0010
381 GENE MUTATION 2 0.0010
382 WRONG DRUG ADMINISTERED 9 0.0010
383 ARTERIOSPASM CORONARY 4 0.0010
384 THROMBOPHLEBITIS SUPERFICIAL 3 0.0010
385 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 5 0.0010
386 OSTEOLYSIS 2 0.0010
387 HYPOTENSION 196 0.0010
388 DIASTOLIC DYSFUNCTION 3 0.0010
389 TALIPES 3 0.0010
390 HYPERPYREXIA 4 0.0009
391 HYPERKINESIA 2 0.0009
392 NYSTAGMUS 5 0.0009
393 AORTIC VALVE INCOMPETENCE 4 0.0009
394 LEFT VENTRICULAR HYPERTROPHY 4 0.0009
395 JAW FRACTURE 2 0.0009
396 EXPOSED BONE IN JAW 2 0.0009
397 MYOCLONUS 11 0.0009
398 HYPERTHERMIA 7 0.0009
399 SINUS TACHYCARDIA 13 0.0009
400 PROCEDURAL COMPLICATION 7 0.0009
401 BRONCHOSPASM 13 0.0009
402 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 3 0.0009
403 RESPIRATORY DISTRESS 25 0.0009
404 THERAPEUTIC AGENT TOXICITY 3 0.0009
405 CALCINOSIS 2 0.0009
406 ANAPHYLACTIC SHOCK 23 0.0009
407 COMPUTERISED TOMOGRAM ABNORMAL 2 0.0009
408 BLOOD LOSS ANAEMIA 2 0.0009
409 BLOOD PRESSURE SYSTOLIC DECREASED 4 0.0009
410 BRONCHOPNEUMONIA 3 0.0009
411 METABOLIC ACIDOSIS 28 0.0009
412 METASTATIC MALIGNANT MELANOMA 2 0.0009
413 TACHYCARDIA 77 0.0009
414 PULMONARY HYPERTENSION 18 0.0009
415 GENERALISED TONIC-CLONIC SEIZURE 14 0.0008
416 PULSE ABSENT 4 0.0008
417 PARAESTHESIA ORAL 12 0.0008
418 SINUS BRADYCARDIA 8 0.0008
419 ASPIRATION 9 0.0008
420 RESPIRATORY DEPRESSION 10 0.0008
421 HEPARIN-INDUCED THROMBOCYTOPENIA 4 0.0008
422 TACHYPNOEA 11 0.0008
423 INFREQUENT BOWEL MOVEMENTS 2 0.0008
424 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 3 0.0008
425 CONJUNCTIVAL HAEMORRHAGE 3 0.0008
426 COMMUNICATION DISORDER 3 0.0008
427 EJECTION FRACTION DECREASED 12 0.0008
428 VENOUS THROMBOSIS 3 0.0008
429 CIRCULATORY COLLAPSE 13 0.0008
430 VAGINAL HAEMORRHAGE 33 0.0008
431 AZOTAEMIA 3 0.0008
432 MUSCLE DISORDER 6 0.0007
433 PRODUCT LABEL ISSUE 5 0.0007
434 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 7 0.0007
435 CONTRAINDICATED PRODUCT ADMINISTERED 22 0.0007
436 HEART RATE ABNORMAL 4 0.0007
437 LUNG CONSOLIDATION 2 0.0007
438 MITRAL VALVE INCOMPETENCE 8 0.0007
439 MYOCARDIAL ISCHAEMIA 8 0.0007
440 NEUROLOGICAL SYMPTOM 4 0.0007
441 OXYGEN SATURATION DECREASED 39 0.0007
442 SUBARACHNOID HAEMORRHAGE 7 0.0007
443 TOOTH INFECTION 9 0.0007
444 GROWTH RETARDATION 2 0.0007
445 HYDRONEPHROSIS 5 0.0007
446 ATRIOVENTRICULAR BLOCK SECOND DEGREE 2 0.0007
447 NO THERAPEUTIC RESPONSE 8 0.0007
448 MEDICAL DEVICE DISCOMFORT 2 0.0007
449 ISCHAEMIA 3 0.0007
450 INTRACARDIAC THROMBUS 2 0.0007
451 CONGENITAL ANOMALY 5 0.0006
452 PROTEINURIA 12 0.0006
453 VENTRICULAR FIBRILLATION 7 0.0006
454 TRICUSPID VALVE INCOMPETENCE 5 0.0006
455 SUPRAVENTRICULAR TACHYCARDIA 6 0.0006
456 HYPOVOLAEMIC SHOCK 3 0.0006
457 HYPONATRAEMIA 35 0.0006
458 POOR QUALITY DRUG ADMINISTERED 4 0.0006
459 CARDIOMYOPATHY 9 0.0006
460 OTITIS MEDIA 2 0.0006
461 ANXIETY DISORDER 2 0.0006
462 LEFT VENTRICULAR DYSFUNCTION 4 0.0006
463 METASTASES TO SPINE 2 0.0006
464 MOTOR DYSFUNCTION 6 0.0006
465 HYPERTRANSAMINASAEMIA 4 0.0006
466 HYPERREFLEXIA 2 0.0006
467 BRONCHIOLITIS 2 0.0006
468 LUNG INFILTRATION 5 0.0006
469 BRADYCARDIA 30 0.0006
470 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 5 0.0006
471 ACUTE RESPIRATORY DISTRESS SYNDROME 10 0.0006
472 APHASIA 17 0.0006
473 FIBRIN D DIMER INCREASED 2 0.0006
474 DEVELOPMENTAL DELAY 5 0.0006
475 VISUAL FIELD DEFECT 4 0.0006
476 HAEMOGLOBIN DECREASED 56 0.0005
477 CARDIAC ARREST 45 0.0005
478 HEPATIC CANCER STAGE IV 2 0.0005
479 DRUG WITHDRAWAL SYNDROME NEONATAL 8 0.0005
480 STREPTOCOCCAL INFECTION 3 0.0005
481 THERAPY NON-RESPONDER 24 0.0005
482 PULMONARY CONGESTION 7 0.0005
483 DEPRESSED LEVEL OF CONSCIOUSNESS 21 0.0005
484 SHOCK 12 0.0005
485 POST PROCEDURAL COMPLICATION 10 0.0005
486 HAEMOLYSIS 4 0.0005
487 ATELECTASIS 5 0.0005
488 PANIC DISORDER 2 0.0005
489 CARDIOPULMONARY FAILURE 2 0.0005
490 BODY TEMPERATURE DECREASED 5 0.0005
491 PROTHROMBIN TIME PROLONGED 3 0.0005
492 FUNGAL SKIN INFECTION 2 0.0005
493 ENURESIS 2 0.0005
494 BODY TEMPERATURE INCREASED 10 0.0005
495 CARDIOGENIC SHOCK 7 0.0005
496 CARDIOMEGALY 6 0.0005
497 ANAPHYLACTOID REACTION 2 0.0005
498 EMBOLISM 4 0.0005
499 VENTRICULAR EXTRASYSTOLES 5 0.0005
500 CARDIO-RESPIRATORY ARREST 20 0.0005
501 DERMATITIS ALLERGIC 6 0.0005
502 BRAIN OEDEMA 6 0.0005
503 FACE OEDEMA 8 0.0005
504 INTESTINAL STENOSIS 2 0.0005
505 BUNDLE BRANCH BLOCK LEFT 2 0.0005
506 MENTAL STATUS CHANGES 13 0.0005
507 DRUG RESISTANCE 12 0.0005
508 UNRESPONSIVE TO STIMULI 12 0.0005
509 PSYCHOLOGICAL TRAUMA 4 0.0005
510 MULTI-ORGAN FAILURE 8 0.0005
511 HEPATIC LESION 2 0.0005
512 ATRIOVENTRICULAR BLOCK FIRST DEGREE 2 0.0005
513 URINE OUTPUT DECREASED 4 0.0005
514 HAEMATOCRIT DECREASED 9 0.0005
515 CARDIAC FAILURE ACUTE 3 0.0004
516 ATRIOVENTRICULAR BLOCK COMPLETE 3 0.0004
517 GASTROINTESTINAL INFECTION 4 0.0004
518 DYSKINESIA 18 0.0004
519 INFARCTION 3 0.0004
520 LUMBAR VERTEBRAL FRACTURE 2 0.0004
521 BUNDLE BRANCH BLOCK RIGHT 2 0.0004
522 DYSPAREUNIA 2 0.0004
523 GRAND MAL CONVULSION 4 0.0004
524 LOCALISED OEDEMA 2 0.0004
525 LARGE INTESTINE PERFORATION 3 0.0004
526 HAEMORRHAGE 45 0.0004
527 HYPERKALAEMIA 15 0.0004
528 ABORTION INDUCED 4 0.0004
529 HEART RATE INCREASED 42 0.0004
530 VENTRICULAR TACHYCARDIA 7 0.0004
531 FAECAL INCONTINENCE 2 0.0004
532 ACUTE RESPIRATORY FAILURE 8 0.0004
533 HORMONE LEVEL ABNORMAL 2 0.0004
534 BLINDNESS TRANSIENT 3 0.0004
535 HYPERVOLAEMIA 2 0.0004
536 PALLOR 11 0.0004
537 GASTROINTESTINAL SOUNDS ABNORMAL 2 0.0004
538 ABORTION SPONTANEOUS 16 0.0004
539 INJURY 28 0.0004
540 VAGINAL DISCHARGE 4 0.0004
541 DYSPHORIA 2 0.0004
542 PHLEBITIS 2 0.0004
543 ATRIOVENTRICULAR BLOCK 3 0.0004
544 BENIGN PROSTATIC HYPERPLASIA 2 0.0004
545 BRONCHOPULMONARY ASPERGILLOSIS 3 0.0004
546 PULMONARY HAEMORRHAGE 3 0.0004
547 ANHEDONIA 10 0.0004
548 BLOOD PRESSURE DECREASED 25 0.0004
549 ANAL ABSCESS 2 0.0004
550 PRURITUS GENERALISED 8 0.0004
551 HIP SURGERY 2 0.0004
552 CHOLELITHIASIS 12 0.0004
553 AUTISM SPECTRUM DISORDER 2 0.0004
554 COAGULOPATHY 6 0.0004
555 MALNUTRITION 4 0.0004
556 ANGIOPATHY 2 0.0004
557 TRANSIENT ISCHAEMIC ATTACK 12 0.0004
558 RESTLESSNESS 13 0.0004
559 INADEQUATE ANALGESIA 3 0.0004
560 MULTIPLE ORGAN DYSFUNCTION SYNDROME 10 0.0004
561 CHOLECYSTITIS ACUTE 2 0.0004
562 FACIAL PARALYSIS 3 0.0004
563 CHEST DISCOMFORT 36 0.0004
564 HYPERTONIA 2 0.0003
565 PYELONEPHRITIS 3 0.0003
566 HYPERTRIGLYCERIDAEMIA 2 0.0003
567 TUMOUR LYSIS SYNDROME 3 0.0003
568 PREGNANCY WITH CONTRACEPTIVE DEVICE 3 0.0003
569 MUSCLE RIGIDITY 4 0.0003
570 JAUNDICE 9 0.0003
571 LEUKOCYTOSIS 6 0.0003
572 PNEUMONIA BACTERIAL 3 0.0003
573 HYPERTENSION 69 0.0003
574 INTERVERTEBRAL DISC DEGENERATION 3 0.0003
575 DRUG DIVERSION 2 0.0003
576 ALTERED STATE OF CONSCIOUSNESS 7 0.0003
577 MUSCULOSKELETAL CHEST PAIN 5 0.0003
578 BLOOD ALKALINE PHOSPHATASE INCREASED 8 0.0003
579 INFUSION SITE EXTRAVASATION 2 0.0003
580 GAMMA-GLUTAMYLTRANSFERASE INCREASED 7 0.0003
581 COMA 15 0.0003
582 PLEURAL EFFUSION 19 0.0003
583 HYPOGLYCAEMIA 15 0.0003
584 CHILLS 36 0.0003
585 MEDICATION ERROR 17 0.0003
586 HEPATOMEGALY 3 0.0003
587 DRUG INEFFECTIVE 402 0.0003
588 ORAL CANDIDIASIS 4 0.0003
589 WHEEZING 18 0.0003
590 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
591 BLOOD PRESSURE INCREASED 46 0.0003
592 BRAIN INJURY 3 0.0003
593 THROMBOSIS 24 0.0003
594 EYELID PTOSIS 3 0.0003
595 NEPHROTIC SYNDROME 2 0.0003
596 JOINT EFFUSION 2 0.0003
597 DROOLING 2 0.0003
598 PROCEDURAL PAIN 8 0.0003
599 HAEMOPTYSIS 8 0.0003
600 EXTRASYSTOLES 2 0.0003
601 FEBRILE NEUTROPENIA 19 0.0003
602 TRANSFUSION 3 0.0003
603 ENCEPHALOPATHY 7 0.0003
604 RENAL PAIN 3 0.0003
605 PANIC REACTION 2 0.0003
606 PELVIC PAIN 5 0.0003
607 LOSS OF CONSCIOUSNESS 35 0.0003
608 MOUTH HAEMORRHAGE 2 0.0003
609 DENTAL CARIES 3 0.0003
610 AGRANULOCYTOSIS 5 0.0003
611 PULMONARY MASS 4 0.0003
612 RESPIRATORY DISORDER 8 0.0003
613 BLOOD COUNT ABNORMAL 4 0.0003
614 ACIDOSIS 2 0.0003
615 AGITATION 19 0.0003
616 EYELID OEDEMA 3 0.0003
617 HEART RATE DECREASED 9 0.0003
618 SEPTIC SHOCK 11 0.0003
619 BLOOD LACTATE DEHYDROGENASE INCREASED 4 0.0003
620 PNEUMOTHORAX 4 0.0003
621 CHOLECYSTITIS 3 0.0003
622 ANGIOEDEMA 11 0.0002
623 MYASTHENIA GRAVIS 2 0.0002
624 PRODUCT ADMINISTRATION ERROR 5 0.0002
625 NOCTURIA 3 0.0002
626 CONVULSION 14 0.0002
627 ESCHERICHIA INFECTION 2 0.0002
628 GENERALISED OEDEMA 3 0.0002
629 ACUTE CORONARY SYNDROME 2 0.0002
630 ILEUS 3 0.0002
631 HEMIPLEGIA 2 0.0002
632 LIP SWELLING 8 0.0002
633 ASCITES 7 0.0002
634 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 13 0.0002
635 HEMIPARESIS 4 0.0002
636 INFUSION SITE PAIN 3 0.0002
637 ANURIA 2 0.0002
638 DIPLOPIA 6 0.0002
639 ANKYLOSING SPONDYLITIS 3 0.0002
640 DRUG ERUPTION 4 0.0002
641 SWOLLEN TONGUE 7 0.0002
642 INCORRECT ROUTE OF DRUG ADMINISTRATION 8 0.0002
643 ANAL INCONTINENCE 2 0.0002
644 HYPOTHYROIDISM 7 0.0002
645 ACCIDENTAL OVERDOSE 8 0.0002
646 OFF LABEL USE 191 0.0002
647 PROSTATIC SPECIFIC ANTIGEN INCREASED 3 0.0002
648 APHONIA 3 0.0002
649 BLOOD SODIUM DECREASED 4 0.0002
650 FEELING HOT 13 0.0002
651 HEPATOCELLULAR INJURY 3 0.0002
652 BLOOD CREATINE PHOSPHOKINASE INCREASED 6 0.0002
653 PRESCRIBED OVERDOSE 4 0.0002
654 DYSTONIA 4 0.0002
655 PRODUCT USE IN UNAPPROVED INDICATION 51 0.0002
656 CEREBRAL INFARCTION 5 0.0002
657 DISORIENTATION 8 0.0002
658 OVARIAN CYST 2 0.0002
659 TOXIC EPIDERMAL NECROLYSIS 3 0.0002
660 BONE MARROW FAILURE 4 0.0002
661 DRUG DISPENSING ERROR 3 0.0002
662 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 2 0.0002
663 RIB FRACTURE 4 0.0002
664 PHARMACEUTICAL PRODUCT COMPLAINT 5 0.0002
665 EMOTIONAL DISTRESS 23 0.0002
666 CHEST PAIN 35 0.0002
667 ASPARTATE AMINOTRANSFERASE INCREASED 10 0.0002
668 PYREXIA 64 0.0002
669 MUSCULAR WEAKNESS 21 0.0002
670 INTERVERTEBRAL DISC PROTRUSION 4 0.0002
671 STAPHYLOCOCCAL INFECTION 6 0.0002
672 RESPIRATORY ARREST 5 0.0002
673 FUNGAL INFECTION 6 0.0002
674 STEVENS-JOHNSON SYNDROME 4 0.0002
675 HYPERTENSIVE CRISIS 2 0.0002
676 THERAPEUTIC PRODUCT EFFECT DECREASED 8 0.0002
677 RESPIRATORY FAILURE 13 0.0002
678 BLOOD CALCIUM DECREASED 2 0.0002
679 CANDIDA INFECTION 3 0.0002
680 HEART RATE IRREGULAR 4 0.0002
681 VOMITING 83 0.0002
682 PRODUCT AVAILABILITY ISSUE 4 0.0002
683 SCAR 3 0.0002
684 CHOLECYSTECTOMY 2 0.0002
685 SEIZURE 20 0.0002
686 PERICARDIAL EFFUSION 4 0.0002
687 BACTERAEMIA 2 0.0002
688 BLOOD CREATININE INCREASED 11 0.0002
689 GALLBLADDER DISORDER 3 0.0002
690 THIRST 3 0.0002
691 DYSPNOEA 95 0.0002
692 DRUG EFFECT INCOMPLETE 6 0.0002
693 PRESYNCOPE 4 0.0002
694 LIVER INJURY 4 0.0002
695 DRUG ADMINISTRATION ERROR 5 0.0002
696 EMOTIONAL DISORDER 5 0.0002
697 HYPERCALCAEMIA 2 0.0002
698 ANXIETY 46 0.0002
699 GASTROOESOPHAGEAL REFLUX DISEASE 13 0.0002
700 DYSARTHRIA 6 0.0002
701 HYPOCALCAEMIA 3 0.0002
702 ABDOMINAL PAIN LOWER 4 0.0002
703 FLUSHING 16 0.0002
704 GENERAL PHYSICAL HEALTH DETERIORATION 18 0.0002
705 GENITAL HAEMORRHAGE 2 0.0002
706 HIATUS HERNIA 2 0.0002
707 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
708 CHOKING 3 0.0002
709 NODULE 2 0.0002
710 DEAFNESS 4 0.0002
711 TINNITUS 7 0.0002
712 SKIN DISCOLOURATION 7 0.0002
713 INCORRECT PRODUCT STORAGE 2 0.0002
714 UPPER LIMB FRACTURE 3 0.0002
715 IRRITABILITY 9 0.0001
716 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 5 0.0001
717 ALANINE AMINOTRANSFERASE INCREASED 9 0.0001
718 GINGIVAL BLEEDING 2 0.0001
719 ABDOMINAL PAIN 34 0.0001
720 PRODUCT PREPARATION ERROR 3 0.0001
721 DEPENDENCE 8 0.0001
722 RHABDOMYOLYSIS 6 0.0001
723 COORDINATION ABNORMAL 2 0.0001
724 MASS 2 0.0001
725 LYMPHOPENIA 2 0.0001
726 DIALYSIS 2 0.0001
727 PRURITUS 54 0.0001
728 OVERDOSE 30 0.0001
729 TREMOR 23 0.0001
730 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
731 FAECES DISCOLOURED 3 0.0001
732 FLUID OVERLOAD 2 0.0001
733 GASTROENTERITIS 2 0.0001
734 DYSSTASIA 4 0.0001
735 DYSPHAGIA 13 0.0001
736 PULMONARY EMBOLISM 13 0.0001
737 PALPITATIONS 16 0.0001
738 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
739 INFLUENZA 15 0.0001
740 RASH PAPULAR 3 0.0001
741 HYPOAESTHESIA 20 0.0001
742 SPEECH DISORDER 7 0.0001
743 HYPERHIDROSIS 17 0.0001
744 DEVICE FAILURE 2 0.0001
745 PLATELET COUNT DECREASED 14 0.0001
746 ERYTHEMA 27 0.0001
747 DISCOMFORT 8 0.0001
748 ANAEMIA 25 0.0001
749 EPILEPSY 4 0.0001
750 MUSCLE TWITCHING 3 0.0001
751 PHARYNGEAL OEDEMA 2 0.0001
752 DISTURBANCE IN ATTENTION 7 0.0001
753 LUNG INFECTION 2 0.0001
754 NAUSEA 101 0.0001
755 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 9 0.0001
756 ABNORMAL BEHAVIOUR 5 0.0001
757 SEPSIS 14 0.0001
758 DRUG WITHDRAWAL SYNDROME 11 0.0001
759 CARDIAC FAILURE CONGESTIVE 10 0.0001
760 MENTAL IMPAIRMENT 3 0.0001
761 BLOOD POTASSIUM INCREASED 2 0.0001
762 DEEP VEIN THROMBOSIS 8 0.0001
763 SWELLING FACE 8 0.0001
764 EYE DISORDER 4 0.0001
765 DRUG LEVEL INCREASED 2 0.0001
766 INFUSION RELATED REACTION 8 0.0001
767 DRUG INTERACTION 19 0.0001
768 GAIT INABILITY 4 0.0001
769 TOXICITY TO VARIOUS AGENTS 20 0.0001
770 CONDITION AGGRAVATED 36 0.0001
771 RENAL FAILURE ACUTE 5 0.0001
772 PRODUCT QUALITY ISSUE 16 0.0001
773 PRODUCT USE ISSUE 22 0.0001
774 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
775 ABDOMINAL PAIN UPPER 24 0.0001
776 THROMBOCYTOPENIA 13 0.0001
777 RASH GENERALISED 3 0.0001
778 HAEMATOMA 3 0.0001
779 DEVICE DEFECTIVE 2 0.0001
780 DEVICE DISLOCATION 5 0.0001
781 OEDEMA PERIPHERAL 14 0.0001
782 INCORRECT DOSE ADMINISTERED BY DEVICE 3 0.0001
783 EOSINOPHILIA 2 0.0001
784 AMENORRHOEA 2 0.0001
785 HEAD DISCOMFORT 2 0.0001
786 CEREBRAL HAEMORRHAGE 4 0.0001
787 FEAR 3 0.0001
788 GASTROENTERITIS VIRAL 2 0.0001
789 OSTEOMYELITIS 2 0.0001
790 INTENTIONAL OVERDOSE 7 0.0001
791 NEPHROLITHIASIS 5 0.0001
792 ABNORMAL DREAMS 3 0.0001
793 TREATMENT FAILURE 9 0.0001
794 UPPER RESPIRATORY TRACT INFECTION 5 0.0001
795 FEELING COLD 3 0.0001
796 BACK PAIN 25 0.0001
797 PAIN 66 0.0001
798 NECK PAIN 6 0.0001
799 HEPATIC FUNCTION ABNORMAL 4 0.0001
800 EPISTAXIS 8 0.0001
801 DRUG DEPENDENCE 17 0.0001
802 RENAL FAILURE 14 0.0001
803 BLOOD URINE PRESENT 2 0.0001
804 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
805 RED BLOOD CELL COUNT DECREASED 3 0.0001
806 SOMNOLENCE 21 0.0001
807 CHOLESTASIS 2 0.0001
808 BLOOD GLUCOSE DECREASED 5 0.0001
809 DRUG PRESCRIBING ERROR 2 0.0001
810 INTENTIONAL PRODUCT MISUSE 9 0.0001
811 URINARY INCONTINENCE 3 0.0001
812 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
813 BLOOD PRESSURE ABNORMAL 2 0.0001
814 DEVICE ISSUE 9 0.0001
815 LEUKOPENIA 5 0.0001
816 BURNING SENSATION 7 0.0001
817 DEVICE MALFUNCTION 7 0.0001
818 LACRIMATION INCREASED 3 0.0001
819 ACUTE KIDNEY INJURY 15 0.0001
820 PERIPHERAL SWELLING 15 0.0001
821 HYPERSENSITIVITY 18 0.0001
822 CARDIAC DISORDER 9 0.0001
823 POLLAKIURIA 4 0.0001
824 DRUG-INDUCED LIVER INJURY 3 0.0001
825 URTICARIA 16 0.0001
826 MUSCULOSKELETAL PAIN 5 0.0001
827 PARAESTHESIA 15 0.0001
828 KNEE ARTHROPLASTY 2 0.0001
829 NEUROPATHY PERIPHERAL 9 0.0001
830 CONFUSIONAL STATE 15 0.0001
831 RASH PRURITIC 5 0.0001
832 CHRONIC KIDNEY DISEASE 7 0.0001
833 VISUAL ACUITY REDUCED 3 0.0001
834 THROAT IRRITATION 4 0.0001
835 ANGER 3 0.0001
836 CARDIAC FAILURE 7 0.0001
837 DELIRIUM 3 0.0001
838 NEOPLASM PROGRESSION 3 0.0001
839 ABDOMINAL DISTENSION 9 0.0001
840 RENAL DISORDER 4 0.0001
841 COUGH 24 0.0001
842 SWELLING 8 0.0001
843 NASAL CONGESTION 5 0.0001
844 ARRHYTHMIA 4 0.0001
845 DISEASE RECURRENCE 4 0.0001
846 MOBILITY DECREASED 6 0.0001
847 DEPRESSION 19 0.0001
848 DIABETIC KETOACIDOSIS 2 0.0001
849 INCORRECT DOSE ADMINISTERED 19 0.0001
850 WRONG TECHNIQUE IN DRUG USAGE PROCESS 3 0.0001
851 CONSTIPATION 18 0.0001
852 THERAPEUTIC RESPONSE DECREASED 5 0.0001
853 C-REACTIVE PROTEIN INCREASED 3 0.0001
854 NEURALGIA 2 0.0001
855 HEADACHE 51 0.0001
856 DYSPEPSIA 8 0.0001
857 EXTRAPYRAMIDAL DISORDER 2 0.0001
858 AGGRESSION 4 0.0001
859 DYSPNOEA EXERTIONAL 3 0.0001
860 ASTHMA 9 0.0001
861 HOT FLUSH 6 0.0001
862 HAEMATEMESIS 2 0.0001
863 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
864 HEPATITIS 2 0.0001
865 SINUSITIS 8 0.0001
866 NO ADVERSE EVENT 14 0.0001
867 PLASMA CELL MYELOMA 3 0.0001
868 AMNESIA 5 0.0001
869 GASTRITIS 2 0.0001
870 NASOPHARYNGITIS 14 0.0001
871 DEHYDRATION 10 0.0001
872 MENSTRUATION IRREGULAR 2 0.0001
873 BLOOD BILIRUBIN INCREASED 2 0.0001
874 OEDEMA 4 0.0001
875 MOOD ALTERED 2 0.0001
876 DEVICE DELIVERY SYSTEM ISSUE 2 0.0001
877 CONTUSION 7 0.0001
878 HAEMATOCHEZIA 4 0.0001
879 ROAD TRAFFIC ACCIDENT 3 0.0001
880 WITHDRAWAL SYNDROME 3 0.0001
881 RENAL IMPAIRMENT 6 0.0001
882 SLEEP DISORDER 5 0.0001
883 OSTEOARTHRITIS 3 0.0001
884 SYNCOPE 7 0.0001
885 HYPERSOMNIA 2 0.0001
886 HYPOACUSIS 3 0.0001
887 LETHARGY 4 0.0001
888 LIVER FUNCTION TEST ABNORMAL 2 0.0001
889 NEEDLE ISSUE 2 0.0001
890 BONE PAIN 4 0.0001
891 SURGERY 4 0.0001
892 PNEUMONIA 22 0.0001
893 INSOMNIA 18 0.0001
894 WEIGHT INCREASED 15 0.0001
895 GASTROINTESTINAL DISORDER 6 0.0001
896 BLOOD POTASSIUM DECREASED 2 0.0001
897 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
898 DIABETES MELLITUS 5 0.0001
899 VISION BLURRED 9 0.0001
900 INJECTION SITE SWELLING 5 0.0001
901 ADVERSE EVENT 6 0.0001
902 HYPOKALAEMIA 3 0.0001
903 DIZZINESS 32 0.0001
904 NERVOUS SYSTEM DISORDER 2 0.0001
905 MIGRAINE 6 0.0001
906 PRODUCTIVE COUGH 3 0.0001
907 CYSTITIS 2 0.0001
908 RASH ERYTHEMATOUS 3 0.0001
909 DRUG INTOLERANCE 6 0.0001
910 RHINORRHOEA 4 0.0001
911 LACTIC ACIDOSIS 2 0.0001
912 RHEUMATOID ARTHRITIS 7 0.0001
913 ATRIAL FIBRILLATION 6 0.0001
914 ASTHENIA 23 0.0001
915 INFLUENZA LIKE ILLNESS 5 0.0001
916 DEVICE DIFFICULT TO USE 4 0.0001
917 DECREASED APPETITE 14 0.0001
918 RASH 26 0.0001
919 CELLULITIS 3 0.0001
920 MYALGIA 10 0.0001
921 HEPATIC ENZYME INCREASED 4 0.0001
922 HAEMATURIA 2 0.0001
923 ACCIDENTAL EXPOSURE TO PRODUCT 6 0.0001
924 DEVICE USE ERROR 2 0.0001
925 PANCREATITIS 3 0.0001
926 LYMPHADENOPATHY 2 0.0001
927 DRUG EFFECT DECREASED 3 0.0001
928 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
929 MYELOSUPPRESSION 2 0.0001
930 ARTHRALGIA 23 0.0001
931 CRYING 2 0.0001
932 MUSCLE SPASMS 10 0.0001
933 PAIN IN EXTREMITY 16 0.0001
934 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 11 0.0001
935 INJECTION SITE MASS 2 0.0001
936 EYE SWELLING 2 0.0001
937 PANCYTOPENIA 3 0.0001
938 UNEVALUABLE EVENT 4 0.0001
939 COVID-19 9 0.0001
940 ARTHRITIS 4 0.0001
941 WEIGHT DECREASED 14 0.0001
942 INJECTION SITE HAEMORRHAGE 4 0.0001
943 FEELING ABNORMAL 12 0.0001
944 SUICIDE ATTEMPT 3 0.0000
945 EXTRA DOSE ADMINISTERED 2 0.0000
946 DIARRHOEA 31 0.0000
947 MENTAL DISORDER 2 0.0000
948 MYOCARDIAL INFARCTION 8 0.0000
949 PRODUCT STORAGE ERROR 4 0.0000
950 INTENTIONAL PRODUCT USE ISSUE 4 0.0000
951 MUSCULOSKELETAL STIFFNESS 4 0.0000
952 MALAISE 20 0.0000
953 LIVER DISORDER 2 0.0000
954 COGNITIVE DISORDER 2 0.0000
955 OCULAR HYPERAEMIA 2 0.0000
956 FALL 14 0.0000
957 GAIT DISTURBANCE 8 0.0000
958 ABDOMINAL DISCOMFORT 7 0.0000
959 JOINT SWELLING 5 0.0000
960 LUNG DISORDER 2 0.0000
961 BRONCHITIS 3 0.0000
962 VISUAL IMPAIRMENT 5 0.0000
963 INJECTION SITE ERYTHEMA 5 0.0000
964 FLUID RETENTION 2 0.0000
965 ILLNESS 4 0.0000
966 INJECTION SITE BRUISING 3 0.0000
967 NEUTROPENIA 5 0.0000
968 ALOPECIA 7 0.0000
969 URINARY TRACT INFECTION 6 0.0000
970 HERPES ZOSTER 2 0.0000
971 FATIGUE 27 0.0000
972 INFECTION 5 0.0000
973 HOSPITALISATION 5 0.0000
974 DRUG DOSE OMISSION 5 0.0000
975 MALIGNANT NEOPLASM PROGRESSION 3 0.0000
976 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
977 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5 0.0000
978 DEATH 23 0.0000
979 HALLUCINATION 2 0.0000
980 DRUG DOSE OMISSION BY DEVICE 2 0.0000
981 DRY MOUTH 2 0.0000
982 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
983 PRODUCT DOSE OMISSION ISSUE 7 0.0000
984 CEREBROVASCULAR ACCIDENT 4 0.0000
985 BALANCE DISORDER 2 0.0000
986 INJECTION SITE PAIN 7 0.0000
987 DISEASE PROGRESSION 2 0.0000
988 DRY SKIN 2 0.0000
989 MEMORY IMPAIRMENT 2 0.0000
990 BLOOD GLUCOSE INCREASED 2 0.0000